Bombay Oxygen Investments Ltd

As of November 3, 2025, Bombay Oxygen is considered risky and overvalued, with a PE ratio of -42.06 and poor financial metrics compared to peers like Linde India and Petronet LNG, alongside a year-to-date stock performance of -16.78%, significantly underperforming the Sensex's 7.47% gain.

Bombay Oxygen's historical performance from 2009 to 2011 shows consistent growth in net sales and profits, with net sales increasing from 32.51 Cr to 41.74 Cr and profit after tax rising from 0.59 Cr to 4.15 Cr. However, cash flow from operating activities declined from 3.74 Cr to -0.42 Cr, indicating cash management challenges despite overall profitability.

Bombay Oxygen's historical performance from 2009 to 2011 showed steady growth in net sales and profits, with net sales increasing from 32.51 Cr to 41.74 Cr and profit after tax rising from 0.59 Cr to 4.15 Cr. However, cash flow from operating activities turned negative in March 2011, indicating potential liquidity issues despite overall profitability.

Bombay Oxygen's latest results are concerning, showing a net loss of ₹5.22 crore in Q2 FY26 and a dramatic 56.23% revenue decline for the first half of the fiscal year, indicating significant operational challenges and a challenging outlook for the company.

Bombay Oxygen has shown steady growth in net sales and profits from 2009 to 2011, with net sales increasing from 32.51 Cr to 41.74 Cr and profit after tax rising from 0.59 Cr to 4.15 Cr. However, cash flow from operating activities turned negative in March 2011, indicating potential cash generation challenges despite overall profitability.

As of 10-Oct, Bombay Oxygen Investments Ltd is facing a decline in stock price, currently at 24,741.35, with a total loss of 2.59% over the last two days and negative returns across various time frames. The stock is underperforming compared to the benchmark Sensex, indicating a challenging environment and reduced investor confidence.

Bombay Oxygen's historical performance from 2009 to 2011 shows steady growth in net sales and profits, with net sales increasing from 32.51 crore to 41.74 crore and profit after tax rising from 0.59 crore to 4.15 crore. However, cash flow from operating activities turned negative in 2011, indicating challenges in cash generation despite profitability growth.

As of 24-Sep, Bombay Oxygen Investments Ltd is priced at 26,054.10, having gained 0.22% recently but showing a year-to-date decline of 11.84%. Despite short-term gains, the stock underperforms compared to the Sensex, indicating a negative overall trend.

As of 23-Sep, Bombay Oxygen Investments Ltd is priced at 25,996.00, having increased by 0.71% after two days of decline. Despite a strong three-year return, the stock has faced short-term struggles with a year-to-date decline of 12.03% and a significant drop of 25.26% over the past year, amid declining investor confidence.

As of 22-Sep, Bombay Oxygen Investments Ltd is currently priced at 25,997.90, reflecting a 0.58% increase today, but has underperformed over the past year with a -23.76% return. Despite recent investor interest and a low debt-to-equity ratio, the stock's overall trend shows significant challenges, including declining profits and an expensive valuation relative to peers.

As of 19-Sep, Bombay Oxygen Investments Ltd's stock price is Rs 26,188.00, down 0.56% after a trend reversal. Despite recent declines, it has outperformed its sector today and shows increased investor interest, although it has underperformed over the past month and year compared to the Sensex.

As of 18-Sep, Bombay Oxygen Investments Ltd is currently priced at Rs 26,335.00, reflecting a recent short-term gain despite a significant year-to-date decline of -10.89%. The stock's positive short-term performance contrasts with its longer-term financial challenges, including declining net sales and profits.

As of 17-Sep, Bombay Oxygen Investments Ltd is currently priced at Rs 25,784.00, reflecting a recent increase but showing mixed performance with a year-to-date drop of 12.75%. Despite strong long-term returns, declining investor participation raises concerns about future momentum.

As of 16-Sep, Bombay Oxygen Investments Ltd's stock price is 25,612.00, down 1.48%, and has underperformed its sector. The company faces significant financial challenges, with declining sales and profits, leading to a year-to-date drop of 13.33% and a poor annual return of -26.40%.

As of 15-Sep, Bombay Oxygen Investments Ltd is priced at Rs 25,996.00, having gained 0.29% recently but down 12.03% year-to-date and 24.19% over the past year, with significant declines in net sales and profit. The stock is considered expensive compared to peers, and declining investor participation indicates a lack of confidence, contributing to its long-term volatility.

As of 12-Sep, Bombay Oxygen Investments Ltd is currently priced at 25,920.00, reflecting a 2.44% increase after a trend reversal. Despite recent gains, concerns about declining profits and a premium valuation compared to peers suggest the price increase may not be sustainable long-term.